Enzo Biochem Cash Flow Statement

Financials in millions USD. Fiscal year is August - July.

Millions USD. Fiscal year is Aug - Jul.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 1994
Net Income	20.29	-18.26	7.88	-28.52	2.49	-10.32	-2.5	45.29	-2.29	-9.98	Upgrade
Depreciation & Amortization	2.68	2.83	2.65	2.78	3.04	3.13	3.6	3.84	3.79	3.97	Upgrade
Share-Based Compensation	3.15	2.34	1.64	1.77	1.79	1.64	1.56	1.23	1.09	1.23	Upgrade
Other Operating Activities	-63.09	-3.5	-11.78	6.79	-2.51	2.81	-2.85	2.77	-6.3	3.08	Upgrade
Operating Cash Flow	-36.98	-16.59	0.39	-17.18	4.81	-2.74	-0.21	53.13	-3.7	-1.7	Upgrade
Capital Expenditures	-2.76	-3.47	-4.44	-2.17	-8.13	-1.89	-1.75	-1.53	-1.78	-0.84	Upgrade
Acquisitions	101.74	0	0	0	0	0	0	0	0	0	Upgrade
Change in Investments	0	28.7	-30.06	0	0	0	0	0	0	0	Upgrade
Other Investing Activities	-	-	-	-	-	-0.06	0	0.02	0.03	0.01	Upgrade
Investing Cash Flow	98.98	25.22	-34.5	-2.17	-8.13	-1.94	-1.75	-1.51	-1.75	-0.83	Upgrade
Share Issuance / Repurchase	0.4	0.03	0.1	0	0.17	0.89	0.45	0.09	6.69	11.54	Upgrade
Debt Issued / Paid	-1.53	-0.27	-0.34	7	4.03	-0.33	-2.12	-2.02	-0.46	-0.63	Upgrade
Financing Cash Flow	-1.13	-0.24	-0.24	7	4.19	0.56	-1.67	-1.93	6.23	10.92	Upgrade
Exchange Rate Effect	-0.11	-0.06	0.01	0.07	-0.02	-0.01	0.01	-0.02	-0.12	0.06	Upgrade
Net Cash Flow	60.77	8.33	-34.34	-12.28	0.86	-4.13	-3.61	49.67	0.65	8.45	Upgrade
Free Cash Flow	-39.74	-20.06	-4.05	-19.35	-3.32	-4.62	-1.96	51.6	-5.48	-2.54	Upgrade
Free Cash Flow Margin	-127.93%	-61.46%	-3.44%	-25.45%	-4.09%	-4.58%	-1.86%	50.20%	-5.62%	-2.64%	Upgrade
Free Cash Flow Per Share	-0.81	-0.41	-0.08	-0.41	-0.07	-0.10	-0.04	1.12	-0.12	-0.06	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).